
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
VANCOUVER, British Columbia, April 18, 2019 — The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (Frankfurt:YG3) is pleased to announce it is developing a unique selection of Urban Juve products exclusively for men. Featuring amber and tobacco—two […]
Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]
Beckerman will represent Elixinol’s position in hemp industry’s dynamic U.S. regulatory and advocacy environment DENVER , Jan 03, 2019 — Elixinol, a wholly owned subsidiary of Elixinol Global (EXL) (asx:EXL) announces Joy Beckerman’s appointment to Elixinol’s […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.